North America Smart Insulin Pen Market Outlook to 2024 - Projected to Grow at 9.3% CAGR - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 26, 2019--The “North America Smart Insulin Pen Market (2018 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The North America Smart Insulin Pen Market is expected to witness market growth of 9.3% CAGR during the forecast period 2018-2024. The market research report covers the analysis of key stake holders of the market.
Insulin pens have gained popularity in the recent years. Consequently, smart insulin pens are gaining prominence in their adoption for supplying insulin externally, and as a result, they offer better diabetes management system. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens.
Another benefit of the devices is, it allows dialing the dose accurately, and serving people with vision problems administer insulin easily further contributed to the market growth. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand.
Nevertheless, some limitations prevail that limit the market growth, such as such as two types of insulin cannot be mixed in an insulin pen, therefore, leading more number of injections. Smart insulin pens are best in many ways as compared to other insulin delivery devices. These pens are easier to use than syringe and are portable, which makes them easy to be used anywhere.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.4.1 North America Smart Insulin Pen Market, by Product
1.4.2 North America Smart Insulin Pen Market, by Usability
1.4.3 North America Smart Insulin Pen Market, by End User
1.4.4 North America Smart Insulin Pen Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Smart Insulin Pen Market by Product
3.1.1 North America Second Generation Pens Market by Country
3.1.2 North America First Generation Pens Market by Country
Chapter 4. North America Smart Insulin Pen Market by Usability
4.1.1 North America Prefilled Market by Country
4.1.2 North America Reusable Market by Country
Chapter 5. North America Smart Insulin Pen Market by End User
5.1.1 North America Hospitals & Clinics Market by Country
5.1.2 North America Ambulatory Surgical Centers Market by Country
5.1.3 North America Other End User Market by Country
Chapter 6. North America Smart Insulin Pen Market by Country
6.1 USA Smart Insulin Pen Market
6.2 Canada Smart Insulin Pen Market
6.3 Mexico Smart Insulin Pen Market
6.4 Rest of North America Smart Insulin Pen Market
Chapter 7. Company Profiles
7.1 Companion Medical, Inc.
7.2 Digital Medics Ptd Ltd.
7.3 Eli Lilly and Company
7.4 Novo Nordisk A/S
7.5 Diamesco Co. Ltd.
7.6 F. Hoffmann-La Roche Ltd.
7.7 Insulet Corporation
7.8 Bigfoot Biomedical
7.9 Emperra GmbH E-Health Technologies
7.10 Jiangsu Delfu medical device Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/r43m2w/north_america?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190226005654/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Diabetes Devices,Endocrine and Metabolic Disorders Drugs
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/26/2019 07:51 AM/DISC: 02/26/2019 07:51 AM